Clinical Trial Update: Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

View source ↗

Summary

A completed clinical trial evaluated dosing strategies and outcomes for erythropoietic stimulating therapies in patients with chemotherapy-induced anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• erythropoietic stimulating therapy (ESA) (erythropoietin-stimulating agent)

Snippet

Sponsor: Ortho Biotech Products, L.P. | Conditions: Anemia, Cancer | Status: COMPLETED